Skip to main content
HR 832 117th Congress House Health Administrative law and regulatory procedures Canada Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Prescription drugs Trade restrictions

Safe and Affordable Drugs from Canada Act of 2021

Introduced: February 4, 2021 Introduced by: Pingree, Chellie Democratic · Maine See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2021
Referred to the Subcommittee on Health.
Feb 4, 2021
Referred to the House Committee on Energy and Commerce.
Feb 4, 2021
Introduced in House
 Plain-English summary Congressional Research Service

Safe and Affordable Drugs from Canada Act of 2021

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA shall publish a list of approved Canadian pharmacies on a website.

What's happening now February 5, 2021

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2